Pfizer Animal Health is now offering 50-mL bottles of the respiratory treatment, DRAXXIN® (tulathromycin).

The new 50-mL bottle treats nearly 4,500 pounds (approximately nine 500-pound cattle or 45 100-pound pigs), making DRAXXIN more convenient for veterinary practitioners and producers who have fewer animals to treat or those who want the flexibility, ease and convenience of a smaller bottle. Veterinarians who carry and dispense DRAXXIN will appreciate the additional convenience provided by the new 50-mL size, especially when working in the field or in ambulatory situations. Customers have a number of choices, with the 100-, 250- and 500-mL bottles still available.

In cattle, DRAXXIN is a unique, single-dose therapy for the first-line treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni (Haemophilus somnus) and is the only antibiotic labeled for the treatment of BRD caused by Mycoplasma bovis. Furthermore, DRAXXIN is labeled for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni (Haemophilus somnus).